Market Overview

Benchmark Company Reiterates Buy Rating, $87 PT on Analogic Corporation on Ultrasonix Acquisition

Share:
Related ALOG
Top 4 NASDAQ Stocks In The Medical Laboratories & Research Industry With The Highest EPS
Mid-Day Gainers From December 10: Layne Christensen, Keurig Green Mountain, Burlington Stores And More

In a report published Friday, Benchmark Company reiterated its Buy rating and $87.00 price target on Analogic Corporation (NASDAQ: ALOG).

Benchmark Company noted, “ALOG announced that the company completed the Ultrasonix Medical acquisition. Ultrasonix Medical is a supplier of advanced ultrasound systems for the point-of-care and general imaging markets with over 5,000 systems installed worldwide. We believe that this acquisition brings multiple benefits including an expanded product line, additional customers for cross-selling opportunities and an expanded sales channel including the sales and marketing infrastructure.”

Analogic Corporation closed on Thursday at $74.00.

Latest Ratings for ALOG

DateFirmActionFromTo
Sep 2014Brean CapitalDowngradesBuyHold
Jun 2014BenchmarkMaintainsBuy
Mar 2014CJS SecuritiesDowngradesMarket OutperformMarket Perform

View More Analyst Ratings for ALOG
View the Latest Analyst Ratings

Posted-In: Benchmark CompanyAnalyst Color Reiteration Analyst Ratings

 

Related Articles (ALOG)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→